To hear about similar clinical trials, please enter your email below
Trial Title:
The Role of Autoimmunity and Obesity in Polycystic Ovary Syndrome
NCT ID:
NCT05929950
Condition:
Polycystic Ovary Syndrome
Conditions: Official terms:
Polycystic Ovary Syndrome
Obesity
Autoimmune Diseases
Syndrome
Conditions: Keywords:
autoimmunity
obesity
Polycystic ovary syndrome
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
The goal of the study is to detect autoantibodies in the serum of the women with PCOS and
evaluate the obesity markers to investigate the the role of autoimmunity and obesity in
PCOS
Criteria for eligibility:
Study pop:
women
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- patients diagnosed with PCOS according to the Rotterdam (2003) criteria.
Exclusion Criteria:
- Patients with other causes of hyperandrogenism as congenital adrenal hyperplasia,
androgen-secreting tumors, Cushing's syndrome, hyperprolactinemia, virilizing
ovarian or adrenal tumors and those taking drugs affecting insulin resistance, such
as estrogens, oral contraceptives and corticosteroids during the previous three
months before the study.
Gender:
Female
Gender based:
Yes
Gender description:
because the study is about polycystic ovary syndrome
Minimum age:
12 Years
Maximum age:
55 Years
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Sohag university
Address:
City:
Sohag
Country:
Egypt
Contact:
Last name:
Ola AH Hamed, assistant lecturer
Phone:
2001061137434
Email:
ola.hamed@med.sohag.edu.eg
Start date:
August 1, 2023
Completion date:
June 1, 2024
Lead sponsor:
Agency:
Sohag University
Agency class:
Other
Source:
Sohag University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05929950
